Pursuant to the CARES Act, and in response to the requests from stakeholders, the United States Patent and Trademark Office (USPTO) is extending the time period for petitioning for certain rights of priority or benefit in a patent application, and waiving the associated petition fee.
At the end of September 2014, at the Biotechnology Industry Organization (BIO) IP & Diagnostic Symposium, attendees learned additional information regarding the new United States Patent and Trademark Office (USPTO) guidelines, which were supposed to be released by the end of October. Unfortunately, we are now at the end of November and the guidelines still […]
When filing a patent with the USPTO (United States Patent and Trademark Office), an inventor of a process, machine, manufacture, or composition of matter, or of any new and useful improvement thereof, must file a document known as an Inventor’s Declaration, in which the inventor certifies that he is in fact the original or an […]
The America Invents Act was signed into law by President Barack Obama on September 16, 2011, and took final effect on March 16, 2013. It is an overhaul of the U.S. patent system and serves to more closely align the U.S. system with the way the rest of the world operates. One of the biggest […]
I’m happy to announce my trip to my homeland of Italy for a unique combination of business and pleasure. I left on September 3rd and expect to return to the United States on September 22nd. During my trip, I will be visiting family and close friends in my home city of Venice, and will then […]
A series of recent Supreme Court cases have left the state of patent law in flux, and what happens next is really anyone’s guess. The Court’s decisions in Bilski v. Kappos, Mayo Collaborative Services v. Prometheus Laboratories, Inc. and Association For Molecular Pathology v. Myriad Genetics, Inc. have resulted in scores of patent applications being rejected […]
I opened my own firm, SILVIA SALVADORI, P.C., in April of this year. My practice areas include patents, trademarks, copyright, and ensuring compliance with USFDA (United States Food and Drug Administration or FDA) regulations.
My focus is in patent prosecution and compliance with FDA regulations. These two areas actually go hand in hand. Even clients with successfully-patented products or methods must still obtain approval from the FDA before being allowed to enter the US marketplace, because the rules that govern the FDA are very different than those that govern the US patent office. Therefore my knowledge and experience in practicing in both of these areas is important in allowing me to provide a truly complete service to all of my clients.